AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Adeno-Associated Virus Appears To Reduce Disease Risk.(cervical cancer )

Women's Health Weekly

| April 19, 2001 | COPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 APR 19 - (NewsRx.com & NewsRx.net) -- The presence of a virus appears to reduce the risk of cervical cancer by interfering with another virus that causes the disease, a new study suggests.

Some strains of the sexually transmitted human papillomavirus, or HPV, cause cervical cancer. But women with high levels of the adeno-associated virus, or AAV, are less likely to develop precancerous cervical lesions, said University of South Carolina researcher Ann Coker, the lead author of the study.

"The mechanism by which AAV inhibits cervical cancer is not yet clear," Coker said. "However, there is growing evidence that both viruses infect the same tissue and interaction occurs between the viruses."

The researchers tested 313 women. AAV was present in nearly 71% of those women who had normal Pap smears but was present in only about 54% of those with advanced precancerous cervical lesions. The study was published in the April 2001 issue of Experimental and Molecular Pathology.

"It is an interesting observation because if there is another virus associated with cervical cancer and if it helps to separate the bad actors from the good actors, it could potentially be quite ...

Related articles from newspapers, magazines, journals, and more
Targeted Genetics expands AAV patent portfolio, has exclusive rights to newly...
Newspaper article from: BIOTECH Patent News July 1, 2004 700+ words
...the issuance of an additional patent broadening its AAV (adeno-associated viral) vector technology...Vectors and Host Cells Containing Same" covers AAV vectors with sequences from AAV serotype 1. The patent was issued to University...
Targeted Genetics Expands AAV Patent Portfolio.
Press release article from: PR Newswire July 7, 2004 700+ words
...the issuance of an additional patent broadening its AAV (adeno-associated viral) vector technology...Vectors and Host Cells Containing Same" covers AAV vectors with sequences from AAV serotype 1. The patent was issued to University...
Avigen Licenses AAV Vector Technology to Stratagene.
Press release article from: PR Newswire July 11, 2000 700+ words
...proprietary recombinant adeno-associated virus (AAV) vectors for research purposes. Stratagene...upfront payment and royalties on sales of the AAV kits and other products developed by Stratagene...based research tools, using Avigen's AAV technology. In addition, Avigen will receive...
Targeted Genetics Receives AAV Manufacturing Patent Supporting AIDS Vaccine,...
Press release article from: PR Newswire May 20, 2003 700+ words
...patent related to its adeno-associated virus (AAV) vector manufacturing process. U.S. patent...helper-free preparation of released recombinant AAV vectors." The patent describes an AAV manufacturing process in which the growth conditions...
Targeted Genetics Expands AAV Manufacturing Patent Portfolio.
Press release article from: PR Newswire November 5, 2003 700+ words
...related to its adeno-associated virus (AAV) vector production technology. U.S. patent...titled "Amplifiable Adeno-Associated Virus (AAV) Packaging Cassettes for the Production of Recombinant AAV Vectors," expands Targeted Genetics' production...
Avigen Issued patent for advanced AAV vector.(adeno-associated virus)(Brief...
Newspaper article from: BIOTECH Patent News May 1, 2002 700+ words
...to its growing adeno-associated virus (AAV) vector patent portfolio with the issuance...titled "High-Efficiency Wild-Type-Free AAV Helper Functions." This composition of matter patent covers AAV vector free of wild-type AAV as determined...
Avigen issued three patents expanding AAV portfolio.(adeno-associated virus...
Newspaper article from: BIOTECH Patent News April 1, 2002 700+ words
...intellectual property portfolio in adeno-associated virus (AAV) vector technology. Two of the patents cover advances in the delivery of AAV. The third covers the cells used in Avigen's AAV manufacturing process, which result in significantly enhanced...
TARGETED GENETICS LICENSES IN VIVO AAV TECHNOLOGIES FOR HUMAN GENE THERAPY
Press release article from: PR Newswire April 7, 1994 700+ words
...manufacture and use of adeno-associated virus (AAV) vectors in gene therapy. The company is currently evaluating AAV vectors as potential in vivo gene delivery...agreements covering patent applications for AAV. The National Institutes of Health (NIH...
Targeted Genetics Strengthens Intellectual Property for AAV Vector...
Press release article from: PR Newswire November 7, 2002 700+ words
...covering additional approaches to manufacturing AAV (adeno-associated virus) vectors. The...Associated Viruses" and covers the production of AAV vectors using stable cell lines. The patent...licensed to Targeted Genetics. Production of AAV vectors requires the introduction of several...
Targeted Genetics Strengthens Intellectual Property for AAV Vector...
Press release article from: Business Wire February 10, 2006 700+ words
...patent related to its adeno-associated virus (AAV) vector manufacturing processes. U.S. patent...helper-free preparation of released recombinant AAV vectors." The patent describes an AAV manufacturing process in which numerous growth...
For more facts and information, see all results

Source: HighBeam Research, Adeno-Associated Virus Appears To Reduce Disease Risk.(cervical...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA